Deep brain stimulation in addiction due to psychoactive substance use. 2013

Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
Department of Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany. Electronic address: jens.kuhn@uk-koeln.de.

Addiction is one of the most challenging health problems. It is associated with enormous individual distress and tremendous socioeconomic consequences. Unfortunately, its underlying mechanisms are not fully understood, and pharmacological, psychological, or social interventions often fail to achieve long-lasting remission. Next to genetic, social, and contextual factors, a substance-induced dysfunction of the brain's reward system is considered a decisive factor for the establishment and maintenance of addiction. Due to its successful application and approval for several neurological disorders, deep brain stimulation (DBS) is known as a powerful tool for modulating dysregulated networks and has also been considered for substance addiction. Initial promising case reports of DBS in alcohol and heroin addiction in humans have recently been published. Likewise, results from animal studies mimicking different kinds of substance addiction point in a similar direction. The objective of this review is to provide an overview of the published results on DBS in addiction, and to discuss whether these preliminary results justify further research, given the novelty of this treatment approach.

UI MeSH Term Description Entries
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D046690 Deep Brain Stimulation Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously. Brain Stimulation, Deep,Electrical Stimulation of the Brain,Brain Stimulations, Deep,Deep Brain Stimulations,Stimulation, Deep Brain,Stimulations, Deep Brain
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
January 1987, Journal of psychoactive drugs,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
June 2003, La Revue du praticien,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
April 2003, Lancet (London, England),
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
May 2010, Fortschritte der Neurologie-Psychiatrie,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
January 2013, World neurosurgery,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
January 2006, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
September 2012, Clinical neurology and neurosurgery,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
February 2011, Addiction (Abingdon, England),
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
January 2016, Brain stimulation,
Jens Kuhn, and Christian P Bührle, and Doris Lenartz, and Volker Sturm
August 2011, Addiction (Abingdon, England),
Copied contents to your clipboard!